1. ULK2 suppresses ovarian cancer cell migration and invasion by elevating IGFBP3
   Xiaoxi Chen et al, 2024, PeerJ CrossRef
2. Roles of CDK12 mutations in PCa development and treatment
   Chenye Jiang et al, 2025, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
3. METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor
   Xin Chen et al, 2024, Biomedicine & Pharmacotherapy CrossRef